Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp6 | Acromegaly | ECE2018

IGF-I response to pasireotide LAR treatment in acromegaly is mainly driven by somatostatin receptor subtype 2 expression

Muhammad Ammar , Coopmans Eva , Gatto Federico , Franck Sanne , Janssen Joseph , van der Lelij Aart Jan , Hofland Leo , Neggers Sebastian

Background: The response to first-generation long-acting somatostatin analogues (LA-SSA) treatment in acromegaly depends on the expression of the somatostatin receptor (SSTR) subtypes. In contrast to octreotide and lanreotide which preferentially bind to SSTR2, pasireotide targets multiple SSTRs, with the highest binding affinity for SSTR5. It has previously been suggested that SSTR5 expression could predict the response to pasireotide LAR (PAS-LAR) treatment in acromegaly.</p...

ea0029p1091 | Neuroendocrinology | ICEECE2012

Hypercortisolism in patients with diabetes mellitus, adrenal incidentaloma and obesity

Dreval A. , Komerdus I. , Murzina A. , Nechaeva O.

Some studies reports the high prevalence of unsuspected hypercortisolism in high-risk populations.Aim: To evaluate the prevalence of undiagnosed hypercortisolism in patients with diabetes mellitus (DM), adrenal incidentaloma and obesity.Material and methods: We prospectively evaluated 30 DM patients (8 male, 22 female, 53.5 years old (18; 73), HbA1c-7.1% (5.6; 13.8)), 22 patients with adrenal incidentaloma (6 male, 16 female, 53.5 ...

ea0009p88 | Endocrine tumours and neoplasia | BES2005

Long term culture of MCF-7 breast cancer cells with siRNA to the IGF-I receptor causes continued transcriptional silencing of the IGF-I receptor and decreased cell proliferation

McVittie C , Ogunkolade W , Khalaf S , Macaulay V , Bustin S , Carpenter R , Jenkins P

Introduction: The GH/IGF-I axis has been implicated in the pathogenesis of breast cancer and development of tamoxifen resistance. We have previously used siRNA to successfully silence the IGF-I receptor (IGF-IR) in MCF-7 breast cancer cells. To further characterize the growth changes that occur when elements of the GH/IGF-I axis are disrupted we investigated the use of siRNA to cause long term silencing of IGF-IR.Methods: MCF-7 cells were cultured in phe...

ea0026p711 | Diabetes (epidemiology, pathophysiology) | ECE2011

Vitamin D and gestational diabetes

Pi J , Vallina I F , Alonso F , Penuela I , Caton B , Tutor E , Santos E

Introduction: There is an increasing evidence of vitamin D role in maintaining normal glucose homeostasis. Gestational diabetes (GD) is related to insulin resistance and vitamin D deficiency has been linked with GD risk in some studies.Aims: To assess whether vitamin D levels are related with gestational diabetes in a group of healthy pregnant women.Subjects: The whole group included 845 pregnant women recruited from April 2009 to ...

ea0041ep14 | Adrenal cortex (to include Cushing's) | ECE2016

Adrenal crisis and sick day episodes among CAH patients: preliminary report based on international CAH (I-CAH) registry

Karunasena Nayananjani , Daniel Eleni , Bryce Jillian , Jiang Jipu , Faisal Ahmed S , Guran Tulay , Mendonca Berenice B , Bachega Tania A , Blankenstein Oliver , Koehler Birgit , Neumann Uta , Acerini Carlo , Krone Nils , Bonfig Walter , Mohnike Klaus , Elsedfy Heba , Ross Richard

Background: Congenital adrenal hyperplasia (CAH) is a rare condition that is associated with life long risk of adrenal crisis. Management of CAH demands a fine balance between excess glucocorticoid leading to adverse effects and too little glucocorticoid risking adrenal crises. Frequent occurrence of sick day episodes warrants dose adjustment and education regarding adrenal crisis. In a condition such as CAH it is difficult to collect sufficient data from small cohorts at a si...

ea0041ep874 | Pituitary - Clinical | ECE2016

Discrepant GH and IGF-I values in the evaluation of treated acromegalic patients; an ongoing challenge. A meta-analysis

Kanakis George , Chrisoulidou Alexandra , Bargiota Alexandra , Efstathiadou Zoe , Papanastasiou Lamprini , Theodoropoulou Anastasia , Tigas Stylianos , Vassiliadi Dimitra , Tsagarakis Stylianos , Alevizaki Maria

Purpose: Growth Hormone (GH) and Insulin-like Growth Factor 1 (IGF-I) are currently the principal biomarkers used to assess disease activity in acromegaly and any discrepancy between them renders interpretation of results inconclusive. The purpose of this study was to assess the frequency of discrepant results and identify parameters that might affect the emergence of this phenomenon.Methods: A systematic review of Medline and Scopus was performed (1987&...

ea0038p405 | Steroids | SFEBES2015

Cytosolic innate immune receptor RIG-I amplifies glucocorticoid action within lung epithelial cells

Sai Shuji

Glucocorticoids (GC) influence immune responses, and exogenous GC are widely used clinically for their potent anti-inflammatory effects. Endogenous GC action is modulated by pre-receptor GC metabolising enzyme 11β-hydroxysteroid dehydrogenase (11b-HSD). 11b-HSD1 predominantly reactivates GCs, amplifying their action. Recent work has shown that 11b-HSD1 modulates immune and inflammatory response. However how innate immune system affect GC metabolism within cells remains la...

ea0022p550 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Angiotensin converting enzyme I/D and M235T angiotensinogen gene polymorphism in patients with acromegaly

Turgut Sebahat , Akin Fulya , Kursunluoglu Raziye , Turgut Gunfer

Background: Acromegaly is associated with increased morbidity and mortality from cardiovascular disease. Hypertension is a number of common cardiovascular risk factors in acromegalic patients. The aim of this study was to investigate association between the frequencies of angiotensin converting enzyme (ACE) I/D and angiotensinogen (AGT) M235T polymorphisms, the genes belongs to the renin–angiotensin–aldosterone system, and clinical parameters of acromegaly patients.<...

ea0020p545 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

Pre-treatment IGF-I concentrations predict radiographic osteoarthritis in acromegalic patients with long-term cured disease

Biermasz Nienke R , Wassenaar Moniek J E , van der Klaauw Agatha A , Pereira Alberto M , Smit Johannes W A , Roelfsema Ferdinand , Wolterbeek Ron , Kroon Herman M , Kloppenburg Margreet , Romijn Johannes A

Objective: To identify factors influencing the development of osteoarthritis during long-term control of acromegaly, focusing on disease specific parameters, growth hormone (GH) and insulin-like growth factor I (IGF-I) concentrations and duration of disease, adjusted for the well-known determinants of primary osteoarthritis.Design: Follow-up study.Methods: We studied 67 patients, with adequate biochemical control of acromegaly for ...

ea0056p665 | Growth hormone IGF axis - basic | ECE2018

Effects of zinc, magnesium and vitamin B6 (ZMA) supplementation on serum IGF-I, IGFBP-3 and Testosterone concentrations in young athletes

Cerqueira Henrique , Filho Hugo Tourinho , Martinelli Jr Carlos

Background: The GH-IGF system plays an important role in strength gain. Some studies suggest that Zinc, Magnesium and Pyridoxine (ZMA) supplementation could increase GH/IGF and testosterone levels in young subjects. This hypothetical increase could lead to significant changes in body composition. ZMA is a very popular supplement, easily found in specialty stores, and it is presumed to increase GH, IGF-I and testosterone levels. However, studies are divergent regarding its effi...